Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of LB1148 in Accelerating the Time to Return of Bowel Function in Subjects Undergoing Planned Bowel Resection (INTEGRITY)

NCT05470387 is registered in ClinicalTrials.gov with Palisade Bio as lead sponsor.

NCT NCT05470387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05470387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of LB1148 in Accelerating the Time to Return of Bowel Function in Subjects Undergoing Planned Bowel Resection (INTEGRITY)
Lead sponsor
Palisade Bio
Phase
Phase 3
Overall status
Terminated
Start date
June 28, 2022
Completion date
August 11, 2023
Enrollment
23 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

gastro-intestinal disorder, ileus